Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Sanofi-Aventis To Build Flu Plant in Shenzhen

publication date: Nov 28, 2007

Sanofi-Aventis revealed plans to spend 70 million euros ($103 million) to build a flu-vaccine factory in Shenzhen, located in the southern part of China. Construction will begin next year, with expectations that the plant will be operational in 2012. Sanofi admitted its vaccine will be more expensive than those produced by other China manufacturers, presumably domestic China companies. Sanofi does not expect to compete on price, but feels that the Sanofi name, together with the international standards to which the company adheres, would create sufficient appeal for the higher-price Sanofi vaccines. More details...

Stock Symbol: (NYSE: SNY)  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital